Oncogene Cancer Research shared a post on LinkedIn:
“A big thank you to Thermo Fisher Scientific for bringing the patient voice into their recent European meeting.
Our co-founder and Chair, Yvonne Diaz, joined thoracic oncologist Dr Massimiliano Cani and pathologist Dr Erika Toth to share a patient perspective on diagnostics. For our community, biomarker testing is not an abstract system – it is critical. It determines whether patients receive the right treatment at the right time. It often also marks the moment when uncertainty begins to lift: when a diagnosis becomes clear, a treatment pathway is defined, and life can begin again in a different way.
Thank you to our hosts Katharina Sollweck and Philip Jermann for creating space for the patient voice, and to Dr Cani and Dr Toth for a thoughtful and meaningful exchange.
Behind every test is a person waiting for answers – and those moments matter.”
More posts featuring Oncogene Cancer Research.
